Miss Jill Anne Roberts, PHARMD | |
3331 Rainbow Dr, Rainbow City, AL 35906-6205 | |
(256) 442-7275 | |
(256) 442-3633 |
Full Name | Miss Jill Anne Roberts |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 3331 Rainbow Dr, Rainbow City, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972605400 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 14455 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Miss Jill Anne Roberts, PHARMD 6283 Chula Vista Rd, Southside, AL 35907-5650 Ph: (256) 442-2348 | Miss Jill Anne Roberts, PHARMD 3331 Rainbow Dr, Rainbow City, AL 35906-6205 Ph: (256) 442-7275 |
News Archive
Emisphere Technologies, Inc. announced today that it is engaged in ongoing discussions with a potential licensee for its high dose oral Eligen B12 1000mcg as a Medical Food for individuals with B12 deficiency. In addition, the Company is evaluating other potential licensees as well as the possibility of marketing the product without a partner.
On Sunday, Oct. 10, Whole Foods Market and retailers across the country will celebrate Non-GMO Day to raise consumer awareness about the presence of genetically modified organisms (GMOs) in the food supply. Driven by the nonprofit Non-GMO Project, this Sunday's events are designed to send a wakeup call to consumers across the country.
Spinal Modulation, Inc. announced today the completion of its $27.4 million Series C financing. Johnson & Johnson Development Corporation (JJDC) joined existing major investors including DeNovo Ventures, ePlanet/DFJ, Kleiner Perkins Caufield & Byers, and MedVenture Associates in this financing. DFJ/InCube Ventures and Raffles Venture Partners are additional new investors.
The National Institute of Mental Health (NIMH), of the National Institutes of Health (NIH), has awarded a four-year, $9 million contract to the University of California, Los Angeles (UCLA) and five other academic medical centers to create a network of Treatment Units for Research on Neurocognition and Schizophrenia (TURNS).
The NASDAQ OMX Group, Inc. announced today the results of the semi-annual re-ranking of the NASDAQ Biotechnology Index®, which will become effective prior to market open on Monday, May 24, 2010.
› Verified 8 days ago
Dr. Jeri Lynn Cordell, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3331 Rainbow Dr, Rainbow City, AL 35906 Phone: 256-442-7275 | |
Andrew Thomas Prince, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3434 Rainbow Dr, Rainbow City, AL 35906 Phone: 256-413-1767 | |
Dr. Kamila Leigh Staton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3434 Rainbow Dr, Rainbow City, AL 35906 Phone: 256-413-1767 Fax: 256-413-7643 | |
Dr. Justin Michael Bramel, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3434 Rainbow Dr, Rainbow City, AL 35906 Phone: 256-413-1767 | |
Jacee Hubbard Simmons, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3434 Rainbow Dr, Rainbow City, AL 35906 Phone: 256-413-1767 | |
Kathryn Hartline, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3331 Rainbow Dr, Rainbow City, AL 35906 Phone: 256-442-7275 | |
Ingrid Boike Staton, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3331 Rainbow Dr, Rainbow City, AL 35906 Phone: 256-442-7275 |